ClinicalTrials.gov
ClinicalTrials.gov Menu

A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint (PARSC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00903565
Recruitment Status : Active, not recruiting
First Posted : May 18, 2009
Last Update Posted : June 27, 2017
Sponsor:
Information provided by (Responsible Party):
Agendia

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2019
  Estimated Study Completion Date : December 2019